The 10 biggest medtech stories of 2024
As another year draws to a close, we look at the most consequential stories and emergent themes of the year …
Post
-
-
Sotelix raises $1.7m to advance therapeutic endoscopy development
Sotelix Endoscopy has completed a $1.7m funding round that will go towards research, development and the in vivo testing of …
-
Onward wins FDA approval for ARC-EX system in spinal cord injury patients
The US Food and Drug Administration (FDA) has granted de novo classification to Onward Medical for its ARC-EX system in …
-
Mainz Biomed partners with Quest for colorectal cancer screening test
Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test, …
-
Whats ahead for Nvidia in life sciences in 2025
2024has been a good year for US-based technology powerhouse Nvidia. The company has come a long way from their starting …
-
Health tech company ŌURA secures $200m in Series D funding
Finnish health technology company ŌURA has secured $200m in a Series D funding round, raising the company’s valuation to $5.2bn. Fidelity …
-
Imbed Biosciences announces Terry Bromley as new CEO
Wound care technology developer Imbed Biosciences has announced the appointment of Terry Bromley as its new chief executive officer (CEO). With …
-
Axoft granted approval for brain implant trial
Axoft has received approval from the Ministry of Health of Panama and the Panama Clinic's Ethics Committee to conduct a …
-
Vivani begins exenatide implant trial for obesity in Australia
Vivani Medical has commenced the first-in-human, randomised trial, LIBERATE-1, by initiating screening and enrolment to assess the pharmacokinetic and safety …
-
Bridge to Life acquires Medica SpA’s VitaSmart perfusion system
Organ preservation solution company Bridge to Life has acquired Medica SpA’s VitaSmart Hypothermic Machine Perfusion System. Last month, Bridge to Life …
-
FDA expands BiVACOR artificial heart study after successful first implants
The US Food and Drug Administration (FDA) has approved the expansion of BiVACOR’s early feasibility study evaluating its titanium total …
-
Karmanos Cancer Institute commences prescription of liver cancer device
The Barbara Ann Karmanos Cancer Institute, a part of McLaren Health Care, has commenced the prescription of a new radiofrequency …
-
NICE recommends Acurable’s at-home sleep apnoea diagnostic
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Acurable’s wearable AcuPebble device to support the remote …
-
Hologic agrees with CDC to develop reagents for H5N1 bird flu testing
Hologic has agreed with the US Centers for Disease Control and Prevention (CDC) to create analyte-specific reagents (ASRs) that could …
-
ClearNote and Southampton researchers partner for pancreatic cancer test study
ClearNote Health has announced a partnership with the University of Southampton's Clinical Trials Unit researchers to use the Avantect pancreatic …
